Back to Journals » Clinical Ophthalmology » Volume 4

Case of primary diffuse large B-cell lymphoma of lacrimal sac in a Japanese patient

Authors Kajita, Oshitari T, Yotsukura J, Asanagi, Baba T, Kishimoto T, Yamamoto S

Published 23 November 2010 Volume 2010:4 Pages 1351—1354

DOI https://doi.org/10.2147/OPTH.S14675

Review by Single-blind

Peer reviewer comments 3


Fusae Kajita1, Toshiyuki Oshitari1, Jiro Yotsukura1, Kaoru Asanagi1, Takayuki Baba1, Takashi Kishimoto2, Shuichi Yamamoto1
1Department of Ophthalmology and Visual Science, 2Department of Molecular Pathology, Chiba University Graduate School of Medicine, Chiba, Japan

Abstract: The purpose of this study was to determine the characteristics of primary diffuse large B-cell lymphoma (DLBCL) of the lacrimal sac. A 77-year-old man had epiphora of the right eye for three years. After visiting five clinics and hospitals, he was referred to our hospital, and the preoperative magnetic resonance imaging findings suggested a lacrimal sac mass. Dacryocysteography showed an obstruction of the right nasolacrimal duct, so we performed dacryocystectomy. After a histopathologic examination of the specimen, the patient was diagnosed with a DLBCL. Positron emission tomography scanning excluded metastases, and the final diagnosis was made of a primary DLBCL of the right lacrimal sac. He underwent radiotherapy with 30.6 Gray in total to the right lacrimal sac. After radiotherapy, no recurrence has been observed anywhere in his body for one year. Although a malignant lymphoma of the lacrimal sac is rare, clinicians should consider a primary malignant lymphoma in the differential diagnosis in patients with chronic dacryocystitis.

Keywords: lacrimal sac, diffuse large B-cell lymphoma, radiotherapy, dacryocystectomy, Japanese

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]